MeniscoFix™
Total/Sub-Total Meniscal Replacement
Pre-clinicalActive
Key Facts
About NovoPedics
NovoPedics is a private, pre-revenue biotechnology company pioneering a regenerative medicine solution for meniscus repair. Its core technology is MeniscoFix™, a bioresorbable, fiber-reinforced scaffold designed to replace damaged meniscal tissue and be naturally resorbed and replaced by new, native-like tissue. The company has achieved significant non-dilutive funding through NIH SBIR grants and Department of Defense awards, and its device has received FDA Breakthrough Device Designation, indicating a high unmet medical need. NovoPedics is currently in the pre-clinical and development stage, advancing toward clinical trials for a large orthopedic market with limited treatment options.
View full company profile